Pharmaconutrition with selenium in critically ill patients: What do we know?

Nutrition in Clinical Practice

Volumn 30, Issue 1, 2015, Pages 34-43

  Manzanares, William ^a   Langlois, Pascal L ^b   Heyland, Daren K ^c  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

antioxidants; critical care; critical illness; nutritional support; selenium; sepsis; systemic inflammatory response syndrome

Indexed keywords

GLUTAMINE; SELENIUM; SODIUM SELENITE; ANTIOXIDANT; TRACE ELEMENT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG MECHANISM; DRUG SAFETY; ENTERIC FEEDING; HUMAN; INTENSIVE CARE UNIT; MONOTHERAPY; MORTALITY; MULTIPLE ORGAN FAILURE; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PLASMA CONCENTRATION-TIME CURVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELENIUM BLOOD LEVEL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VITAMIN SUPPLEMENTATION; CRITICAL ILLNESS; DIET THERAPY; PROCEDURES; TREATMENT OUTCOME;

ANTIOXIDANTS; CRITICAL ILLNESS; HUMANS; MULTIPLE ORGAN FAILURE; NUTRITION THERAPY; SELENIUM; SODIUM SELENITE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRACE ELEMENTS; TREATMENT OUTCOME;

EID: 84921490959     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533614561794     Document Type: Review

References (78)

1. Rayman MP. Selenium and human health. Lancet. 2012 ; 379: 1256-1268
2. Hardy G, Hardy I, Manzanares W. Selenium supplementation in the critically ill. Nutr Clin Pract. 2012 ; 27: 21-33
3. Fairweather-Tait SJ, Bao Y, Broadley MR, et al. Selenium in human health and disease. Antioxid Redox Signal. 2011 ; 14: 1337-1383
4. Steinbrenner H, Sies H. Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta. 2009 ; 1790: 1478-1485
5. Roman M, Jitaru P, Barbante C. Selenium biochemistry and its role for human health. Metallomics. 2014 ; 6: 25-54
6. Weekley CM, Harris HH. Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem Soc Rev. 2013 ; 42: 8870-8894
7. Heyland DK, Dhaliwal R, Day A, et al. REducing Deaths due to OXidative Stress (The REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc. 2006 ; 65: 250-263
8. Manzanares W, Hardy I, Hardy G 2012 Annual Update in Intensive Care and Emergency Medicine. Vincent JL, ed. Berlin, Germany: Springer-Verlag ; 2012 :
9. Manzanares W, Hardy G. Pharmaconutrition with antioxidants in the critically ill: is selenium the cornerstone of this strategy?. ICU Management. 2012 ; 4: 22
10. Manzanares W, Langlois PL, Hardy G. Update on antioxidant micronutrients in the critically ill. Curr Opin Clin Nutr Metab Care. 2013 ; 16: 719-725
11. Heyland DK, Muscedere J, Wischmeyer P, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013 ; 368: 1489-1497
12. Manzanares W, Heyland DK. Pharmaconutrition with antioxidant micronutrients in the critically ill: the time has come!. Nutrition. 2013 ; 29: 359-360
13. Forceville X, Vitoux D, Gauzit R, et al. Selenium, systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit Care Med. 1998 ; 26: 1536-1544
14. Manzanares W, Biestro A, Galusso F, et al. Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill. Intensive Care Med. 2009 ; 35: 882-889
15. Sakr Y, Reinhart K, Bloos F, et al. Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis and multiorgan failure. Br J Anaesth. 2007 ; 98: 775-784
16. Forceville X, Mostert V, Pierantoni A, et al. Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes. Eur Surg Res. 2009 ; 43: 338-347
17. Manzanares W, Hardy G. Selenium supplementation in the critically ill: posology and pharmacokinetics. Curr Opin Clin Nutr Metab Care. 2009 ; 12: 273-280
18. Vincent JL, Forceville X. Critically elucidating the role of selenium. Curr Opin Anesthesiol. 2008 ; 21: 148-154
19. Forceville X, Van Antwerpen P 2008 Yearbook in Intensive Care and Emergency Medicine. Vincent JL, ed. Berlin, Germany: Springer-Verlag ; 2008: 454-466.
20. Stefanowicz FA, Talwar D, Denis SJ, et al. Erythrocyte selenium concentration as a marker of selenium status. Clin Nutr. 2013 ; 32: 837-842
21. Frisman E, Racz O, Chmélarová A. Red cell antioxidant enzymes and prognostic indexes in patients with burns. Burns. 2013 ; 39: 458-464
22. Geoghegan M, McAuley D, Eaton S, et al. Selenium in critical illness. Curr Opin Crit Care. 2006 ; 12: 136-141
23. Barclay MNI, MacPherson A, Dixon J. Selenium content of a range of UK foods. J Food Composition Anal. 1995 ; 8: 307-318
24. Vanek VW, Borum P, Buchman A. A.S.P.E.N. Position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. Nutr Clin Pract. 2012 ; 27: 440-491
25. Fessler TA. Trace elements in parenteral nutrition: a practical guide for dosage and monitoring for adult patients. Nutr Clin Pract. 2013 ; 28: 722-729
26. Hardy G, Menéndez AM, Manzanares W. Trace element supplementation in parenteral nutrition: pharmacy, posology, and monitoring guidance. Nutrition. 2009 ; 25: 1073-1084
27. Selenium, Environmental Health Criteria 58. Geneva, Switzerland: WHO ; 1987 :
28. Yang G, Zhou R. Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China. J Trace Elem Electrolytes Health Dis. 1994 ; 8: 159-165
29. Sriram K, Lonchyna VA. Micronutrient supplementation in adult nutrition therapy: practical considerations. JPEN J Parenter Enteral Nutr. 2009 ; 33: 548-562
30. Scientific Committee on Food on the TUIL of Selenium. Tolerable upper intake levels of selenium. http://ec.europa.eu/food/fs/sc/scf/out80g-en.pdf. Accessed on September 25, 2014.
31. Shenkin A. Selenium in intravenous nutrition. Gastroenterology. 2009 ; 137: S61 - S69
32. Angstwurm MWA, Gaertner R. Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care. 2006 ; 9: 233-238
33. Schrauzer GN. Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J Nutr. 2000 ; 130: 1653-1656
34. Forceville X. The effect of selenium therapy on mortality in patients with sepsis syndrome: simple selenium supplementation or real (5 H2O).Na2SeO3 pharmacological effect?. Crit Care Med. 2013 ; 41: 1591-1592
35. Jeong DW, Yoo MH, Kim TS, Kim IY. Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-kappa B activation. J Biol Chem. 2002 ; 277: 17871-17876
36. Stewart MS, Spallholz JE, Neldner KH, et al. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med. 1999 ; 26: 42-48
37. Maehira F, Miyagi I, Eguchi Y. Selenium regulates transcription factor NF-κB activation during the acute phase reaction. Clin Chem Acta. 2003 ; 334: 163-171
38. Chung YW, Kim TS, Lee SY, et al. Selenite-induced apoptosis of osteoclasts mediated by the mitochondrial pathway. Toxicol Lett. 2006 ; 160: 143-150
39. Schomburg L. A large-bolus injection, but not continuous infusion of sodium selenite improves outcome in peritonitis. Shock. 2010 ; 33: 554-556
40. Forceville X, Mostert V, Pierantoni A, et al. Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes. Eur Surg Res. 2009 ; 43: 338-347
41. Hurst R, Armah CN, Dainty JR, et al. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2010 ; 91: 923-931
42. Wang Z, Forceville X, Van Antwerpen P, et al. A large bolus, but not a continuous infusion, of sodium selenite improves outcome in peritonitis. Shock. 2009 ; 32: 140-146
43. Huang TS, Shyu YC, Chen HY, et al. Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLoS One. 2013 ; 8: e54431
44. Johnson CC, Fordyce FM, Rayman MP. Symposium on 'Geographical and geological influences on nutrition': factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc Nutr Soc. 2010 ; 69: 119-132
45. Robinson MF, Huemmer PK. Effect of a megadose of ascorbic acid, a meal and orange juice on the absorption of selenium as sodium selenite. N Engl J Med. 1985 ; 98: 627-629
46. Clement IP. Interaction of vitamin C and selenium supplementation in the modification of mammary carcinogenesis in rats. J Natl Cancer Inst. 1986 ; 77: 299-303
47. Heyland DK, Elke G, Cook D, et al. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. :
48. Angstwurm MA, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999 ; 27: 1807-1813
49. van Zanten ARH, Sztark F, Kaisers UX, et al. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU. JAMA. 2014 ; 312: 514-524
50. Zimmermann T, Albrecht S, Kuhne H, et al. Selenium administration in patients with sepsis syndrome: a prospective randomized study. Med Klin. 1997 ; 92: 3-4
51. Angstwurm MWA, Engelmann L, Zimmermann T, et al. Selenium in Intensive Care (SIC) study: results of a prospective, randomized, placebo- controlled, multiple-centre study in patients with severe systemic inflammatory response syndrome, sepsis and septic shock. Crit Care Med. 2007 ; 35: 118-126
52. Mishra V, Baines M, Perry SE, et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr. 2007 ; 26: 41-50
53. Forceville X, Laviolle B, Annane D, et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care. 2007 ; 11: R73
54. Montoya C, Hernández A, Antonio J, et al. Efecto antiinflamatorio del selenio en pacientes sépticos. Rev Asoc Mex Med Crit Ter Int. 2009 ; 23: 199-205
55. Andrews PJD, Avenell A, Noble DW, et al. Randomised trial of glutamine, selenium, or both to supplement parenteral nutrition for critically ill patients. BMJ. 2011 ; 342: d1542
56. Manzanares W, Biestro A, Torre MH, et al. High dose selenium reduces ventilator associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med. 2011 ; 37: 1120-1127
57. Valenta J, Brodska H, Drabek T, et al. High-dose selenium substitution in sepsis: a prospective, randomized clinical trial. Intensive Care Med. 2011 ; 37: 808-815
58. Manzanares W, Dhaliwal R, Jiang X, et al. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care. 2012 ; 16: R66
59. Schneider A, Markowski A, Momma M, et al. Tolerability and efficacy of a low-volume enteral supplement containing key nutrients in the critically ill. Clin Nutr. 2011 ; 30: 599-603
60. Landucci F, Mancinelli P, De Gaudio AR, et al. Selenium supplementation in critically ill patients: a systematic review and meta-analysis. J Crit Care. 2014 ; 29: 150-156
61. Alhazzani W, Jacobi J, Sindi A, et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2013 ; 41: 1555-1564
62. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2013 ; 41: 580-637
63. Heyland DK, Dhaliwal R, Suchner U, et al. Antioxidants nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005 ; 31: 327-337
64. Canadian Clinical Practice Guidelines. 2013. http://www.criticalcarenutrition.com. Accessed August 25, 2014.
65. Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis (SISPCT). 2013. ClinicalTrials.gov. Accessed August 25, 2014.
66. Manzanares W, Biestro A, Galusso F, et al. High-dose selenium for critically ill patients with systemic inflammation: a pilot study. Nutrition. 2010 ; 26: 634-640
67. Klein CJ, Nielsen FH, Moser-Veillon PB. The element loss in urine and effluent following traumatic injury. JPEN J Parenter Enteral Nutr. 2008 ; 32: 129-139
68. Berger MM, Cavadini C, Chiólero R, et al. Cooper, selenium and, zinc status and balances after major trauma. J Trauma. 1996 ; 40: 103-109
69. Olson OE. Selenium toxicity in animals, with emphasis on man. J Am Coll Toxicol. 1986 ; 5: 45-69
70. Geneva, Switzerland: ; 1987 :
71. Forceville X, Touati S, Le Toumelin P, et al. Elements of margin of safety, toxicity and action of sodium selenite in a lipopolysaccharide rat model. J Trace Elem Med Biol. 2014 ; 28: 303-310
72. Hall R. Identification of inflammatory mediators and their modulation by strategies for the management of the systemic inflammatory response during cardiac surgery. J Cardiothorac Vasc Anesth. 2013 ; 27: 983-1033
73. Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 2002 ; 97: 215-252
74. Venardos KM, Perkins A, Headrick J, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem. 2007 ; 14: 1539-1549
75. Stoppe C, Shalte G, Rossaint R, et al. The intraoperative decrease of selenium is associated with the postoperative development of multiorgan dysfunction in cardiac surgical patients. Crit Care Med. 2011 ; 39: 1879-1885
76. Koszta G, Kacska Z, Szatmári K, Szerafin T, Fülesdi B. Lower whole blood selenium level is associated with higher operative risk and mortality following cardiac surgery. J Anesth. 2012 ; 26: 812-821
77. Stoppe C, Spillner J, Rossaint R, et al. Selenium blood concentrations in patients undergoing elective cardiac surgery and receiving perioperative sodium selenite. Nutrition. 2013 ; 29: 158-165
78. Stoppe C, McDonald B, Rex S, et al. SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX(R)-trial): study design of an international multicenter randomized double blinded controlled trial of high dose sodium-selenite administration in high-risk cardiac surgical patients. Trials. 2014 ; 15: 339